Shiny Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-12-2024
- Paid Up Capital ₹ 1.00 M
as on 16-12-2024
- Company Age 18 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.87 M
as on 16-12-2024
- Revenue -12.31%
(FY 2021)
- Profit -76.94%
(FY 2021)
- Ebitda 12.56%
(FY 2021)
- Net Worth 3.99%
(FY 2021)
- Total Assets 0.09%
(FY 2021)
About Shiny Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.87 M.
Pawan Sharma, Vishal Gupta, Ragini Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233GJ2006PTC049634
- Company No.
049634
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shiny Pharmaceuticals Private Limited offer?
Shiny Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pharmaceutical Medicine, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pharmaceutical Tablets.
Who are the key members and board of directors at Shiny Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Sharma  | Additional Director | 11-Jul-2015 | Current |
| Vishal Gupta | Additional Director | 11-Jul-2015 | Current |
| Ragini Gupta | Director | 22-Dec-2006 | Current |
| Suman Sharma | Director | 22-Dec-2006 | Current |
Financial Performance of Shiny Pharmaceuticals.
Shiny Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.31% decrease. The company also saw a substantial fall in profitability, with a 76.94% decrease in profit. The company's net worth moved up by a moderate rise of 3.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiny Pharmaceuticals?
In 2019, Shiny Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 30 Jun 2020 | ₹0.97 M | Open |
Karnataka Bank Ltd. Creation Date: 26 Dec 2013 | ₹7.00 M | Open |
Karnataka Bank Ltd Creation Date: 29 Sep 2012 | ₹1.50 M | Open |
How Many Employees Work at Shiny Pharmaceuticals?
Unlock and access historical data on people associated with Shiny Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiny Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiny Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
